Extended use of orlistat and sibutramine

被引：0
|
作者：
不详
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 82卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [1] Incorrect use of orlistat and sibutramine in clinical practice
    Anna Dahlin
    Björn Beermann
    European Journal of Clinical Pharmacology, 2007, 63 : 205 - 209
  • [2] Incorrect use of orlistat and sibutramine in clinical practice
    Dahlin, Anna
    Beermann, Bjorn
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (02) : 205 - 209
  • [3] The effects of 1 year sibutramine and orlistat use on bone metabolism
    Kilic, F
    Sabuncu, T
    Ucar, E
    Yasar, O
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S155 - S155
  • [4] Obesity drugs:: sibutramine and orlistat
    García-Luna, PP
    Soto, AM
    MEDICINA CLINICA, 2002, 118 (11): : 437 - 438
  • [5] Orlistat and sibutramine beyond weight toss
    Mannucci, Edoardo
    Dicembrini, Ilaria
    Rotella, Francesco
    Rotella, Carlo Maria
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (05) : 342 - 348
  • [6] Comparison of weight reduction and satisfaction of orlistat and sibutramine
    Mekaroonreung, S
    Auamnoy, T
    Thaweechotepatara, P
    VALUE IN HEALTH, 2005, 8 (03) : 405 - 406
  • [7] Drug treatments for obesity: orlistat, sibutramine, and rimonabant
    Padwal, Raj S.
    Majumdar, Sumit R.
    LANCET, 2007, 369 (9555): : 71 - 77
  • [8] Long-term persistence with orlistat and sibutramine
    Holt, Richard I. G.
    DIABETES OBESITY & METABOLISM, 2007, 9 (05): : 766 - 766
  • [9] Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant
    Rubio, Miguel A.
    Gargallo, Manuel
    Millan, Ana Isabel
    Moreno, Basilio
    PUBLIC HEALTH NUTRITION, 2007, 10 (10A) : 1200 - 1205
  • [10] Currently available drugs for the treatment of obesity: Sibutramine and orlistat
    Chaput, J. -P.
    St-Pierre, S.
    Tremblay, A.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (01) : 3 - 10
12345